Xian Wang

Regional variation limits applications of healthy gut microbiome reference ranges and disease models

Yan He, Wei Wu, Huimin Zheng et al. · Nature Medicine · 2018 · 951 citations

Disease Models, Dysbiosis, Microbiota +10

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial

Binghe Xu, Min Yan, Fei Ma et al. · The Lancet Oncology · 2021 · 372 citations

Capecitabine Versus Lapatinib, Breast Oncology, Medicine +8

SLC7A11/xCT in cancer: biological functions and therapeutic implications.

Wenyu Lin, Chaoqun Wang, Guangping Liu et al. · PubMed · 2020 · 271 citations · Full text

Amino Acid Transporters, Pathology, Therapeutic Implications +18

EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells

Weidong Han, Hongming Pan, Yan Chen et al. · PLoS ONE · 2011 · 250 citations · Full text

Immunology, Cell Death, Cancer Biology +16

Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness

Vivian Y. Shin, Jiawei Chen, Isabella Cheuk et al. · Cell Death and Disease · 2019 · 241 citations · Full text